Filing Details
- Accession Number:
- 0001209191-22-041961
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-07-12 18:22:35
- Reporting Period:
- 2022-06-18
- Accepted Time:
- 2022-07-12 18:22:35
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1652724 | Lucira Health Inc. | LHDX | In Vitro & In Vivo Diagnostic Substances (2835) | 272491037 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1840534 | Dan George | 1412 62Nd Street Emeryville CA 94608 | Cfo And Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-06-18 | 1,321 | $1.45 | 46,354 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on June 18, 2021 for 15,000 shares.
- Includes 1,470 shares and 2,552 shares acquired by the reporting person under the Issuer's 2021 Employee Stock Purchase Plan on August 20, 2021 and February 20, 2022, respectively.